Ohlsson S, Tufvesson B, Polling A, Ohlsson K
Department of Surgical Pathophysiology, University Hospital, Malmö, Sweden.
Biol Chem. 1997 Sep;378(9):1055-8. doi: 10.1515/bchm.1997.378.9.1055.
The secretory leucocyte protease inhibitor, SLPI, is a low molecular weight inhibitor of proteases such as elastase and cathepsin G, which are released from leucocytes during phagocytosis. The purpose of this study was to show whether or not SLPI is produced in articular chondrocytes. In articular disorders, the protease-antiprotease balance is disturbed. For this reason it would be interesting to establish the source of SLPI. The presence of SLPI was demonstrated using immunohistochemistry and in situ hybridization, hence we conclude that SLPI is produced in the chondrocytes of human articular cartilage.
分泌型白细胞蛋白酶抑制剂(SLPI)是一种低分子量的蛋白酶抑制剂,可抑制诸如弹性蛋白酶和组织蛋白酶G等蛋白酶,这些蛋白酶在吞噬作用期间从白细胞中释放出来。本研究的目的是表明关节软骨细胞中是否产生SLPI。在关节疾病中,蛋白酶-抗蛋白酶平衡受到干扰。因此,确定SLPI的来源将是很有意义的。使用免疫组织化学和原位杂交证明了SLPI的存在,因此我们得出结论,SLPI是在人关节软骨的软骨细胞中产生的。